Definition
Hydrochlorothiazide is a synthetic sulfamylbenzothiazine derivative that functions as a thiazide diuretic. It is employed primarily to treat hypertension and edema associated with congestive heart failure, renal disease, and liver cirrhosis.
Overview
Hydrochlorothiazide (often abbreviated HCTZ) belongs to the class of low‑dose thiazide diuretics. By inhibiting sodium‑chloride symport in the distal convoluted tubule of the nephron, it promotes urinary excretion of sodium, chloride, and water, thereby reducing plasma volume and peripheral vascular resistance. The drug is administered orally, typically in tablet form, with common dosages ranging from 12.5 mg to 50 mg per day. It may be prescribed as monotherapy or in combination with other antihypertensive agents such as ACE inhibitors, angiotensin‑II receptor blockers, or calcium channel blockers. Common adverse effects include electrolyte disturbances (hypokalemia, hyponatremia), hyperuricemia, hyperglycemia, and photosensitivity.
Etymology / Origin
The name “hydrochlorothiazide” reflects its chemical structure: “hydro‑” denotes the presence of a hydroxyl group, “chloro‑” indicates a chlorine atom attached to the benzothiazine ring, and “‑thiazide” designates its belonging to the thiazide class of diuretics, which are derived from the benzothiadiazine scaffold. The compound was first synthesized in the 1950s by researchers at Merck & Co. during systematic modifications of earlier thiazide diuretics such as chlorothiazide and methyclothiazide.
Characteristics
| Property | Details |
|---|---|
| Chemical formula | C₇H₈ClN₃O₄S₂ |
| Molecular weight | 297.09 g·mol⁻¹ |
| Physical form | White to off‑white crystalline powder |
| Solubility | Sparingly soluble in water; freely soluble in methanol and ethanol |
| Mechanism of action | Inhibits the Na⁺/Cl⁻ cotransporter (NCC) in the distal convoluted tubule, reducing Na⁺ reabsorption |
| Pharmacokinetics | Oral bioavailability ≈ 70 %; peak plasma concentrations reached 2–4 h after dosing; ~60 % bound to plasma proteins; eliminated primarily by renal excretion (≈ 60 % unchanged) with a half‑life of 6–15 h |
| Regulatory status | Approved by the U.S. Food and Drug Administration (FDA) in 1959; available as prescription‑only medication in most jurisdictions |
Related Topics
- Thiazide diuretics – a broader class of drugs sharing the benzothiadiazine core, including chlorthalidone, indapamide, and metolazone.
- Hypertension management – clinical guidelines on blood pressure control that often list thiazides as first‑line therapy.
- Electrolyte disorders – conditions such as hypokalemia and hyponatremia that may arise from diuretic use.
- Renin‑angiotensin‑aldosterone system (RAAS) inhibitors – drug classes frequently combined with hydrochlorothiazide to achieve synergistic antihypertensive effects.
- Pharmacogenomics of diuretics – research examining genetic variations that influence individual responses to thiazide therapy.